Algodign: From Russia with data

When he co-founded Protein Design Labs Inc., Cary Queen brought to the company the idea of using computer modeling to improve proteins - antibodies in the case of PDLI. Now, as chairman of Algodign Inc., he's expanding the idea to small molecules. Although not the first company to use computer-based drug design, Algodign believes its software offers advantages compared to competing

Read the full 614 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE